Monitoring treatment response in community-acquired pneumonia relies on the expected trajectory of clinical and laboratory markers under effective antibiotic therapy: fever, tachycardia, and hypoxia should resolve within roughly 72 hours, and inflammatory markers such as C-reactive protein should fall by approximately 50% every 24 hours once the causative organism is being killed. Failure to follow this expected resolution pattern signals treatment failure and prompts a structured reassessment covering complications, resistant or unusual organisms, and alternative or coexisting diagnoses. This belongs to the domain of respiratory medicine/infectious disease, applying general principles of inflammatory marker kinetics and differential diagnosis to a specific clinical syndrome.
Monitoring treatment response in community-acquired pneumonia relies on the expected trajectory of clinical and laboratory markers under effective antibiotic therapy: fever, tachycardia, and hypoxia …